AI assistant
LABCORP HOLDINGS INC. — Director's Dealing 2022
Feb 15, 2022
30237_dirs_2022-02-15_2abbd774-7e5f-4172-8235-f4816cd2ba6a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2022-02-11
Reporting Person: Schechter Adam H (Director, President & CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-11 | Restricted Stock Unit | $ | A | 7970 | Acquired | Common Stock (7970) | Direct | |
| 2022-02-11 | Non-qualified Stock Options | $276.26 | A | 28100 | Acquired | 2032-02-10 | Common Stock (28100) | Direct |
Footnotes
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2023.
F3: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
F4: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
F5: The option vests in three equal annual installments beginning on the date reflected in this column.